Fused cycloalkylimidazopyridines

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C22930

Patent

active

056485166

ABSTRACT:
6,7-propylene-, butylene-, or pentylene-bridged imidazopyridin-4-amines that induce interferon (.alpha.) biosynthesis in human cells, their pharmaceutical compositions containing such compounds and methods of inducing interferon (.alpha.) biosynthesis and treating viral infections involving the use of such compounds are disclosed.

REFERENCES:
patent: 3899508 (1975-08-01), Wikel
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5175296 (1992-12-01), Gerster
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gerster
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
Tomioka K, Audo K, Takemasa Y, Kozak. J. Am Chem. Soc. (1984), 106 (9), 2718-9.
J. Med. Chem., 1968, 11, 87 (Jain et al.).
J. Org. Chem., 1978, 43, 1460 (Kloek et al.).
Helv. Chem. Acta. 1945, 28, 1684 (Prelog et al.).
J. Med. Chem. 1975, 18, 726 (Buckle et al.).
Methods in Enzymology, 1981, 78, 262-284 (Stringfellow).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fused cycloalkylimidazopyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused cycloalkylimidazopyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused cycloalkylimidazopyridines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1493511

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.